TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT06842186: A Phase 1/2a Study of WVE-007 in Adults Living With Overweight or Obesity

Sponsor: Wave Life Sciences USA, Inc. · Phase: PHASE1/PHASE2 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 400 pts

Competing Trials Overlap

6 Active Trials

Excess Burn Exposure

$9,030,400

Rescue Site Savings

+$5,954,420

Unlock Full NCT06842186 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT06842186 Rescue Dossier →